Ignite Creation Date:
2025-12-25 @ 4:46 AM
Ignite Modification Date:
2026-06-10 @ 11:00 AM
Study NCT ID:
NCT03983018
Status:
COMPLETED
Last Update Posted:
2025-03-21
First Post:
2019-05-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019)
Sponsor:
Region Örebro County
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
EudraCT Number: 2018-004618-17
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |